As a result, five prognostic genes (MMP11, COL10A1, SERPINE1, COL11A1, and EPYC) were identified as eligible based on the criteria (p < 0.1) in the PAAD datasets (Figure 3A). This evidence concerns the gene COL11A1 and pancreatic adenocarcinoma.